MARKET

MYO

MYO

Myomo
AMEX

Real-time Quotes | Nasdaq Last Sale

12.03
+0.08
+0.67%
Closed 16:00 09/22 EDT
OPEN
12.06
PREV CLOSE
11.95
HIGH
12.66
LOW
11.79
VOLUME
251.57K
TURNOVER
--
52 WEEK HIGH
18.88
52 WEEK LOW
4.120
MARKET CAP
68.93M
P/E (TTM)
-5.7074
1D
5D
1M
3M
1Y
5Y
Myomo Contract Listing On Sam.gov For Co.'s 'Custom Artificial Limb' Via Dept. Of Veterans Affairs, No Terms Disclosed
https://sam.gov/opp/51d1ff086a1f486589a01cf4ed1daef5/view
Benzinga · 19h ago
Bridgeway Funds Inc Buys R.R.Donnelley & Sons Co, Invacare Corp, Castlight Health Inc, ...
GuruFocus News · 5d ago
How Good Are Myomo's Earnings? | Return On Capital Employed
According to data from Benzinga Pro, during Q2, Myomo's (AMEX:MYO) reported sales totaled $3.10 million. Despite a 11.35% increase in earnings, the company posted a loss of $2.60 million.
Benzinga · 6d ago
Myomo, Inc. Announces Granting Of Patents In China And Hong Kong
Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb
Benzinga · 09/07 20:33
Myomo, Inc. Announces Granting of Patents in China and Hong Kong
BOSTON, September 07, 2021--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the g...
Business Wire · 09/07 20:30
Exoskeleton Market Size 2021 Explosive Factors of Revenue By Progression Status, Emerging Demands, Recent Trends, Business Opportunity, Share and Forecast To 2027
The Exoskeleton Market is segmented on the lines of its end-user, technology, Stationary Technology and regional. Based on end-user it covers HealthCare, Military and Industrial. Basis of Stationary Technology is segmented into active and passive. Based on...
Heraldkeepers · 09/06 12:23
Myomo, Inc. Announces Participation in Three September Investment Conferences
BOSTON, September 02, 2021--Myomo, Inc. (NYSE American:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that P...
Business Wire · 09/02 20:30
54 Stocks Moving In Tuesday's Mid-Day Session
Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) climbed 79.3% to $14.93 after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy adult volunteers.
Benzinga · 08/10 16:02
More
Forecast
Actual (K USD)
Estimate (K USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of MYO. Analyze the recent business situations of Myomo through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average MYO stock price target is 22.20 with a high estimate of 36.50 and a low estimate of 14.50.
EPS
Institutional Holdings
Institutions: 16
Institutional Holdings: 1.72M
% Owned: 30.10%
Shares Outstanding: 5.73M
TypeInstitutionsShares
Increased
5
181.43K
New
2
182.53K
Decreased
3
53.28K
Sold Out
7
253.27K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.64%
Healthcare Equipment & Supplies
+0.81%
Key Executives
Chairman/President/Founder/Chief Operating Officer/Director
Steve Kelly
Chief Executive Officer/Director
Paul Gudonis
Chief Financial Officer/Chief Accounting Officer
David Henry
General Manager
Jonathan Naft
Other
Fredrick Nahm
No Data
About MYO
Myomo, Inc. is a wearable medical robotics company that offers functional improvement for those with neuromuscular disorders and upper limb paralysis. The Company develops and markets the MyoPro product line. Its MyoPro is a myoelectric-controlled upper limb brace (orthosis), which is a rigid brace used for the purpose of supporting a patient's weak or paralyzed arm to enable and help improve functional activities of daily living (ADLs) in the home and community. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury and other neurological disorders. It primarily provides devices directly to patients and bill their insurance companies. It also sells its products through various other sales channels, including orthotic and prosthetic (O&P) providers, the Veterans Administration (VA) and to its distributors in certain accounts and geographic markets.

Webull offers kinds of Myomo Inc stock information, including AMEX:MYO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MYO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MYO stock methods without spending real money on the virtual paper trading platform.